Poster Abstract Session:
246. Resistant Gram-Negative Infections: CRE Epidemiology
Saturday, October 10, 2015: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:

-

Tracks: Adult ID

Presentations:
Carbapenem-resistant Enterobacteriaceae (CRE) in Bernalillo County, NM, 2013-2014
Erin C. Phipps, DVM, MPH ; Emily B. Hancock, MS ; Nicole Kenslow, MPH
Posters
  • Phipps_IDWeek_Final.pdf (772.9 kB)
  • Results from a Carbapenem-Resistant Enterobacteriaceae (CRE) Point Prevalence Study Conducted at a University Hospital
    Forest Arnold, DO, MSc, FIDSA ; James Snyder, PhD ; Crystal Heishman, MSN, RN, CIC, ONC ; Trevor Wagner, PhD
    What is the rectal colonization rate of the carbapenem-resistant Enterobacteriaceae (CRE) infected cases? What is the decolonization rate of the CRE colonized cases in the hospital?
    Feriha Cilli, Professor ; Oguz Sipahi, Professor ; Bilgin Arda, Professor ; Ayse Uyan, MD ; Munevver Erdinc, MD ; Demet Dikis, ICP ; Nilay Bilgili Korkmaz, ICP ; Nilgun Deniz-Kucukler, ICP ; Nurhayat Kepeli, ICP ; Behiye Ulusoy, ICP ; Sukran Aksit Barik, ICP ; Mehmet Ozinel, Professor ; Sercan Ulusoy, Professor
    Carbapenem-Resistant Enterobacteriaceae (CRE) Exposure of Hospitals and Nursing Homes from Patients in an Academic Medical Center
    Sarah M. Cousins, BS ; Kathleen a. Quan, RN, MSN, CIC ; Chenghau Cao, MPH ; Susan S. Huang, MD, MPH, FIDSA, FSHEA
    Posters
  • CRE-poster-Cousins.pdf (83.7 kB)
  • The Burden and Relative Risk of Carbapenem-resistant Pathogens and Correlations with Antibiotic Usage in a National Managed Care System
    Uzo Chukwuma, MPH ; Michael Sparks, Ph.D. ; Charlotte Neumann, MSc ; Robert Clifford, Ph.D. ; Paige Waterman, M.D. ; Patrick Mc Gann, PhD ; Mary Hinkle, M.D. ; Emil Lesho, DO, FIDSA
    The Clonal Distribution of Extended-Spectrum Cephalosporin-Resistant and Susceptible Extraintestinal E. coli Isolates in a Pediatric Setting
    Amanda Adler, BA ; Arianna Miles-Jay, MPH ; Scott Weissman, MD ; Xuan Qin, PhD ; Matthew Kronman, MD, MSCE ; Jessica Berry, BS ; Jaipreet Rayar, MS ; Jeffrey Myers, BS ; Carey-Ann D. Burnham, PhD ; Alexis Elward, MD, MPH, FSHEA ; Jason Newland, MD, MEd, FPIDS ; Rangaraj Selvarangan, PhD ; Kaede V. Sullivan, MD ; Theoklis Zaoutis, MD, MSCE, FPIDS ; Danielle Zerr, MD, MPH, FPIDS
    Posters
  • IDSA_poster_9_8_15.pdf (454.2 kB)
  • Distribution of Gram-Negative (GN) Pathogens and Carbapenem Resistance (CR) Patterns across United States Hospitals: Will Klebsiella become the new Pseudomonas?
    James a. Mckinnell, MD ; Margaret Griffin, MPH ; Romney Humphries, Ph.D. ; Janet Hindler, MCLS, MT(ASCP) ; Olga Crowley, PhD ; Shanice Bedassie, . ; Kayla Stephenson, . ; Charlie Garland, MBA ; Thomas Lodise, PharmD, PhD
    Emergence of New Delhi Metallo-β – Lactamase (NDM – 1) – Encoding Gene among Gram Negative Bacteria Isolated from Hospital Effluents
    Veena Shetty, Ph.D ; Divyashree M, M.Sc ; Deekshit Vijay Kumar, PhD ; Avinash Shetty, MD, FIDSA ; Indrani Karunasagar, PhD
    Posters
  • Veena Shetty NDM.pdf (665.0 kB)
  • Differential Degree of Air and Environmental Surfaces Contamination by KPC-producing Gram-negative Rods Based on the Body Source
    Luis Shimose, M.D. ; Eriko Masuda, MD ; Ana Berbel Caban, M.D. ; Maroun Sfeir, MD ; Maria X. Bueno, MD ; Dennise Depascale, MT ; Timothy Cleary, PhD ; Yohei Doi, MD, PhD ; L. Silvia Munoz-Price, MD, PhD
    Posters
  • Poster_KPC_092915.pdf (1.0 MB)
  • Chlorhexidine Gluconate (CHG) susceptibility of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae isolates from skin cultures of patients in long-term acute care hospitals (LTACHs)
    Nicholas M. Moore, MS ; Karen Lolans, BS ; Louis Fogg, PhD ; Shayna Weiner, MPH ; Donald Blom, RN, BA ; Rosie D. Lyles, MD, MHA ; Michael Y. Lin, MD, MPH ; David W. Hines, MD ; Robert a. Weinstein, MD, FIDSA, FSHEA ; Mary K. Hayden, MD, FIDSA, FSHEA ; For the CDC Prevention Epicenters Program, .
    Risk Factors for Carbapenem-non-susceptible Pseudomonas aeruginosa Infections Compared to Susceptible Counterparts: a Case-Control Study
    Tina Khadem, PharmD ; Vanessa Stevens, PhD ; Kathleen Holt, PhD, MA, BA ; Chas Hoffmann, PharmD ; Ghinwa Dumyati, MD, FSHEA ; Jack Brown, PharmD, MS, BCPS, FCCP
    An Outbreak with Colistin- and Carbapenem-Resistant Klebsiella pneumoniae in an Intensive Care Unit
    Uluhan Sili, MD, PhD ; Aysun Tekin, MD ; Husniye Karadag, RN ; Gulsen Altinkanat, PhD ; Fethi Gul, MD ; Beliz Bilgili, MD ; Mustafa Kemal Arslantas, MD ; Pinar Ay, MD, PhD ; Guner Soyletir, MD ; Ismail Cinel, MD, PhD ; Volkan Korten, MD
    Economic Impact of Carbapenameses-Producing Enterobacteriaceae Causing Bloodstream Infections in Latin America
    Cristhian Hernandez, Bsc ; Gabriel Motoa, MD ; Christian Pallares, MD, MSc ; Juan Sebastian Muñoz, MD ; Kevin Escandón-Vargas, MD ; Carlos Alvarez, MD, FIDSA ; Fernando Rosso, MD, MSC ; Carlos Seas, MD, FIDSA ; Jose Hidalgo, MD ; Carlos Mejia, MD ; Jeannnete Zurita, MD ; Manuel Guzman-Blanco, MD ; Carlos Luna, MD ; Eduardo Rodríguez, MD ; Manuel CortesÍa, M. D ; Lorena Matta, M.D ; Maria Virginia Villegas, MD, MSc, FIDSA
    An Overview of the Molecular Epidemiology of Carbapenemase-producing Bacteria in the U. S. Military Health System
    Emil Lesho, D.O., FIDSA ; Mary Hinkle, M.D. ; Yoon Kwak, MS ; Ana Ong, BS ; Rosslyn Maybank, BA ; Uzo Chukwuma, MPH ; Charlotte Neumann, MSc ; Katherine Mcauliffe, MPH ; Robert Clifford, Ph.D. ; Eric Steele, MS ; Lakshmi Appalla, MS ; Fatma Onmus-Leone, MS ; Erik Snesrud, BS ; Michael Julius, PMP ; Paige Waterman, M.D. ; Patrick Mc Gann, PhD
    An Outbreak of NDM-1 Klebsiella pneumoniae in a Tertiary Care Hospital in British Columbia – The Role of Molecular Analysis in Determining Transmission
    Manal Tadros, MBBS, MSc, PhD, FRCPC ; Linda MN Hoang, MD, FRCPC ; Matthew Croxen, PhD ; Michael Mulvey, PhD ; Benjamin Mack, MD, FRCPC ; Susan Roman, MD, FRCPC ; Joan Tomblin, MD, FRCPC ; Elizabeth Brodkin, MD ; Adriana Mendes, RN, BScN, CIC ; Ken Fakharuddin, Laboratory technician ; Suk Ching Wong, RN ; Dale Purych, MD, FRCPC
    Posters
  • CRE outbreak Sep29 draft.pdf (664.6 kB)
  • Comparison of Multidrug Resistant Gram Negative Pathogen Detection by Culture and PCR from Surveillance Samples
    Donna Schora, MT(ASCP) ; Barbara Voss, BS ; Kathy Mangold, PhD ; Sanchita Das, MD ; Richard Thomson Jr., PhD ; Irene Dusich, MT(ASCP) ; Marc-Oliver Wright, MT(ASCP), MS, CIC ; Becky Smith, MD ; Lance Peterson, MD, FIDSA, FSHEA
    Clinical outcomes associated with various treatment options for infections caused by Carbapenem-Resistant Klebsiella pneumoniae (CRKP)
    Samantha Rosenthal, PharmD ; Aabha Jain, MD ; Dong Heun Lee, MD ; Tiffany Bias, PharmD, BCPS, AAHIVP
    Impact of Carbapenem-Resistant Pathogens on Mortality among Hospitalized Adult Patients
    Eriko Ogura, MD ; Glenn Magee, MBA ; Juan Camilo Arjona Ferreira, MD ; Mari Ariyasu, BA ; Takuko Sawada, BA ; Roger Echols, M.D, FIDSA ; Tsutae Den Nagata, MD, PhD, FFPM
    What is Best Available Therapy (BAT) for the Treatment of Carbapenem-resistant (CR) Gram-negative Infections in the US?
    Roger Echols, MD, FIDSA ; Bin Cai, MD, MPH, MS, PhD ; Eriko Ogura, MD ; Juan Camilo Arjona Ferreira, MD ; Mari Ariyasu, BA ; Takuko Sawada, BA ; Glenn Magee, BA, MBA ; Tsutae Den Nagata, MD, PhD, FFPM
    Posters
  • IDWeek(#02)_poster 1802.pdf (4.3 MB)
  • CME Credits:

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.